Shu‐Qiang Weng

1.3k total citations
36 papers, 949 citations indexed

About

Shu‐Qiang Weng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shu‐Qiang Weng has authored 36 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Shu‐Qiang Weng's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Ferroptosis and cancer prognosis (5 papers). Shu‐Qiang Weng is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Ferroptosis and cancer prognosis (5 papers). Shu‐Qiang Weng collaborates with scholars based in China, Canada and Germany. Shu‐Qiang Weng's co-authors include Ling Dong, Xizhong Shen, Taotao Liu, Ji‐Min Zhu, Danying Zhang, Xiang‐Nan Yu, Lin Zhu, Guangqi Song, Yu Hu and Hong Zhu and has published in prestigious journals such as PLoS ONE, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Shu‐Qiang Weng

35 papers receiving 939 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu‐Qiang Weng China 17 631 346 138 104 97 36 949
Zhu Liang China 17 556 0.9× 318 0.9× 65 0.5× 153 1.5× 85 0.9× 78 958
Weiping Zhu China 19 435 0.7× 225 0.7× 160 1.2× 76 0.7× 92 0.9× 53 916
Hongmei Cui China 19 712 1.1× 513 1.5× 130 0.9× 158 1.5× 109 1.1× 34 1.1k
Zitong Zhao China 21 580 0.9× 313 0.9× 170 1.2× 88 0.8× 109 1.1× 55 1.0k
Lixin Wang China 19 463 0.7× 324 0.9× 122 0.9× 64 0.6× 78 0.8× 36 876
Ye Jiang China 18 699 1.1× 387 1.1× 359 2.6× 79 0.8× 123 1.3× 49 1.2k
Lina Gao China 17 475 0.8× 288 0.8× 83 0.6× 65 0.6× 80 0.8× 35 939
Kui Sheng Chen China 2 606 1.0× 241 0.7× 216 1.6× 65 0.6× 144 1.5× 5 1.0k
Jia Fei China 17 429 0.7× 194 0.6× 99 0.7× 55 0.5× 53 0.5× 55 884
Yuhui Zang China 19 593 0.9× 389 1.1× 121 0.9× 214 2.1× 92 0.9× 44 1.2k

Countries citing papers authored by Shu‐Qiang Weng

Since Specialization
Citations

This map shows the geographic impact of Shu‐Qiang Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Qiang Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Qiang Weng more than expected).

Fields of papers citing papers by Shu‐Qiang Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Qiang Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Qiang Weng. The network helps show where Shu‐Qiang Weng may publish in the future.

Co-authorship network of co-authors of Shu‐Qiang Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Qiang Weng. A scholar is included among the top collaborators of Shu‐Qiang Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Qiang Weng. Shu‐Qiang Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Guangcong, Kang Song, Jun Du, et al.. (2024). Bismuth-based mesoporous nanoball carrying sorafenib for synergistic photothermal and molecularly-targeted therapy in an orthotopic hepatocellular carcinoma xenograft mouse model. Colloids and Surfaces B Biointerfaces. 245. 114279–114279. 2 indexed citations
2.
3.
Liu, Zhiyong, Xiahui Lin, Hongying Guo, et al.. (2024). Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma. International Journal of Biological Sciences. 20(7). 2763–2778. 9 indexed citations
4.
Tang, Wenqing, et al.. (2023). Comprehensive Investigation Illustrates the Role of M2 Macrophages and Its Related Genes in Pancreatic Cancer. Medicina. 59(4). 717–717. 3 indexed citations
5.
Liu, Zhiyong, Guobo Chen, Xiang Wang, et al.. (2023). Synergistic Photochemo Effects Based on Light‐Activatable Dual Prodrug Nanoparticles for Effective Cancer Therapy. Advanced Healthcare Materials. 12(27). e2301133–e2301133. 10 indexed citations
6.
Wang, Fu, Weiqi Xu, Wanqin Zhang, et al.. (2023). Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway. Hepatology International. 18(2). 636–650. 7 indexed citations
7.
Wang, Xiang, Jialei Sun, Guangcong Zhang, et al.. (2022). Iridium Complex-Loaded Sorafenib Nanocomposites for Synergistic Chemo-photodynamic Therapy of Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. 14(33). 37356–37368. 20 indexed citations
8.
Liu, Zhiyong, Danying Zhang, Xiahui Lin, et al.. (2022). Nalidixic acid potentiates the antitumor activity in sorafenib-resistant hepatocellular carcinoma via the tumor immune microenvironment analysis. Frontiers in Pharmacology. 13. 952482–952482. 3 indexed citations
9.
Sun, Jialei, Ning‐Ping Zhang, Guangcong Zhang, et al.. (2021). Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages. Journal of Translational Medicine. 19(1). 347–347. 36 indexed citations
10.
Yu, Xiang‐Nan, Guangcong Zhang, Jialei Sun, et al.. (2020). Enhanced mLST8 Expression Correlates with Tumor Progression in Hepatocellular Carcinoma. Annals of Surgical Oncology. 27(5). 1546–1557. 11 indexed citations
11.
Shi, Xuan, Taotao Liu, Xiang‐Nan Yu, et al.. (2020). microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit. Oncogene. 39(35). 5768–5781. 41 indexed citations
12.
Zhang, Danying, Shu‐Qiang Weng, Can Cui, Ling Dong, & Xizhong Shen. (2020). Decreased expression of farnesoid X receptor may indicate poor prognosis in patients with colorectal cancer. Translational Cancer Research. 9(7). 4290–4296. 3 indexed citations
13.
Yu, Xiang‐Nan, Hongying Guo, Taotao Liu, et al.. (2019). Upregulated calcium‐binding tyrosine phosphorylation‐regulated protein‐a/b regulates cell proliferation and apoptosis and predicts poor prognosis in hepatocellular carcinoma. Journal of Cellular Biochemistry. 121(4). 2938–2949. 6 indexed citations
14.
Weng, Shu‐Qiang, Harry L.A. Janssen, Ning‐Ping Zhang, et al.. (2019). CAPS1 Suppresses Tumorigenesis in Cholangiocarcinoma. Digestive Diseases and Sciences. 65(4). 1053–1063. 2 indexed citations
15.
Zhang, Danying, Lin Zhu, Hai‐Ning Liu, et al.. (2019). <p>The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease</p>. Drug Design Development and Therapy. Volume 13. 2249–2270. 42 indexed citations
16.
Jiang, Xuemei, Xiang‐Nan Yu, Taotao Liu, et al.. (2018). microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 105. 1147–1154. 85 indexed citations
17.
Zhu, Lin, Danying Zhang, Hong Zhu, et al.. (2017). Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe−/− mice. Atherosclerosis. 268. 117–126. 192 indexed citations
18.
Xue, Rui, Wenqing Tang, Pingping Dong, et al.. (2016). CAPS1 Negatively Regulates Hepatocellular Carcinoma Development through Alteration of Exocytosis-Associated Tumor Microenvironment. International Journal of Molecular Sciences. 17(10). 1626–1626. 9 indexed citations
19.
Weng, Shu‐Qiang, et al.. (2015). Portal hypertension induced by congenital hepatic arterioportal fistula: Report of four clinical cases and review of the literature. World Journal of Gastroenterology. 21(7). 2229–2235. 19 indexed citations
20.
Hu, Tingting, Shu‐Qiang Weng, Wenqing Tang, et al.. (2015). Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer. PLoS ONE. 10(5). e0125281–e0125281. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhu Liang Breakdown of academic impact, for papers by Weiping Zhu Breakdown of academic impact, for papers by Hongmei Cui Breakdown of academic impact, for papers by Zitong Zhao Breakdown of academic impact, for papers by Lixin Wang Breakdown of academic impact, for papers by Ye Jiang Breakdown of academic impact, for papers by Lina Gao Breakdown of academic impact, for papers by Kui Sheng Chen Breakdown of academic impact, for papers by Jia Fei Breakdown of academic impact, for papers by Yuhui Zang
Rankless by CCL
2026